Across TCGA pan-cancer cohorts, CYP4F24P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated CYP4F24P data layer.
The strongest signal is observed in thymoma (THYM), where higher CYP4F24P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CYP4F24P expression acts as an unfavorable survival marker, although some lineages such as READ and PAAD show a favorable association.
THYM, READ, and KIRC are the cancer types where CYP4F24P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.